MedPath

Efficacy and feasibility of Teleneurorehabilitation in Persons with Parkinsons Disease

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: G20- Parkinsons disease
Registration Number
CTRI/2020/08/027300
Lead Sponsor
Investigatorinitiated trial Prof RK Dhamija
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. A clinical diagnosis of idiopathic PD with a disease severity rating of stage 1 to 2.5 on Hoehn and Yahr scale (Supplement 2) within the past two months

2. Age above 18 years

3. Participants who can give written consent

4. Not on any formal rehabilitation

5. Home access to video calling facility

Exclusion Criteria

1. Current participation in any other trial or formal rehabilitation program

2. Cognitive impairment as indicated by a Mini Mental Status Examination (MMSE) score of below 23

3. Other debilitating conditions eg. Hearing or visual impairment that can impede full participation in the study

4. Inability to perform rehabilitation therapy for any reason

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Motor symptoms- Change in MDS-UPDRS III score at baseline and 12 weeks <br/ ><br>Movement Disorder Society-Unified Parkinsonâ??s Disease Rating Scale- Part III Motor Examination (MDS-UPDRS-III) is an 18-item, assessor-rated instrument assessing severity of PD motor symptoms. Each item is scored â??0â?? to â??4â?? on a categorical scale, in which â??0â?? indicates no impairment and â??4â?? represent severe impairment. The total score is 132. Higher scores indicate more motor disabilities. <br/ ><br>Timepoint: 0 (baseline) and 12 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath